Networks of Innovation
Louis Galambos
€ 38.24
FREE Delivery in Ireland
Description for Networks of Innovation
paperback. How private organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market antitoxins and vaccines. Num Pages: 288 pages, 4 colour illus. BIC Classification: 3JJ; KNDP; MBX; MMG. Category: (G) General (US: Trade). Dimension: 228 x 152 x 20. Weight in Grams: 445.
Networks of Innovation offers an historical perspective on the manner in which private-sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp and Dohme, which acquired Mulford in 1929, and upon Merck & Co Inc., which merged with Sharp and Dohme in 1953. By surveying a century of innovation in biologicals, the authors are able to analyze the conditions that either promoted or prevented creative changes in this important industry. They show how the activities of these three ... Read more
Networks of Innovation offers an historical perspective on the manner in which private-sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp and Dohme, which acquired Mulford in 1929, and upon Merck & Co Inc., which merged with Sharp and Dohme in 1953. By surveying a century of innovation in biologicals, the authors are able to analyze the conditions that either promoted or prevented creative changes in this important industry. They show how the activities of these three ... Read more
Product Details
Format
Paperback
Publication date
1997
Publisher
Cambridge University Press United Kingdom
Number of pages
288
Condition
New
Number of Pages
288
Place of Publication
Cambridge, United Kingdom
ISBN
9780521626200
SKU
V9780521626200
Shipping Time
Usually ships in 7 to 11 working days
Ref
99-1
Reviews for Networks of Innovation
'The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.' John Hunt, The Pharmaceutical Journal